Target-controlled infusion of remifentanil to provide analgesia for awake nasotracheal fiberoptic intubations in cervical trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 5, 2010, Pages 1185-1190

  Yeganeh, Naser ^a   Roshani, Bahman ^a   Azizi, Bahram ^b   Almasi, Afshin ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Analgesia; Fiberoptic intubation; MOAA S; Remifentanil; Target Controlled infusion; Trauma

Indexed keywords

LIDOCAINE; MIDAZOLAM; MORPHINE; PHENYLEPHRINE; REMIFENTANIL; SCOPOLAMINE BUTYL BROMIDE;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CERVICAL SPINE INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUS SEDATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG INFUSION; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; INFUSION PUMP; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MALE; MAXILLOFACIAL SURGERY; NASOTRACHEAL INTUBATION; PAIN; PAIN ASSESSMENT; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECALL; TARGET CONTROLLED INFUSION; VISUAL ANALOG SCALE; VITAL SIGN; WAKEFULNESS;

ADOLESCENT; ADULT; ANESTHETICS, INTRAVENOUS; CERVICAL VERTEBRAE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INTUBATION, INTRATRACHEAL; MIDDLE AGED; NOSE; OPTICAL FIBERS; PAIN; PAIN MEASUREMENT; PIPERIDINES; RETROSPECTIVE STUDIES; SPINAL INJURIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78549257394     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181cb4434     Document Type: Article

References (24)

1. Dimitriou V, Iatrou C, Douma A, Athanassiou L, Voyagis GS. Airway management in Greece: a nationwide postal survey. Minerva Anesthe-siol. 2008;74:453-458.
2. Reed AP. Preparation for intubation of the awaked patient. Mt Sinai J Med. 1995;62:10-20.
3. Andel H, Klune G, Andel D, et al. Propofol without muscle relaxant for conventional of fiberoptic nasotracheal intubation: a dose finding study. Anesth Analg. 2000;91:458-461.
4. Randell T, Valli H, Lindgren L. Effects of alfentanil on the responses to awake fiberoptic nasotracheal intubation. Acta Anesthesiol Scand. 1990; 34:59-62.
5. Sutherland AD, Williams RT. Cardiovascular responses and lidocaine absorption in fiberoptic-assisted awake intubation. Anesth Analg. 1986; 65:389-391.
6. White M, Kenny GN. Intravenous propofol anaesthesia using a computerized infusion system. Anaesthesia. 1992;47:633-634.
7. Connor SB, Quill TJ, Jacobs JR. Accuracy of drug infusion pumps under computer control. IEEE Trans Biomed Eng. 1992;39:980-982.
8. Gray JM, Kenny GN. Development of the technology for Diprifusor for propofol. Anaesthesia. 1998;53:357-360.
9. Schraag S, Flaschar J. Delivery performance of commercial target-controlled infusion devices with Diprifuser module. Eur J Anaesthesiol. 2002;19:980-982.
10. Egan TD. Remifentanil pharmacokinetics and pharmacodynamics: a preliminary appraisal. Clin Pharmacokinet. 1995;29:80-94.
11. Reusche MD, Egan TD. Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulation. J Clin Anesth. 1999;11:64-68.
12. Yeganeh N, Roshani B. A bispectral index guided comparison of target-controlled versus manually-controlled infusion of propofol and remifentanil for attenuation of pressor response to laryngoscopy and tracheal intubation. JRMS. 2006;11:302-308.
13. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology. 2000;92:1603-1616.
14. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244-251.
15. Avramov MN, Smith I, White PF. Interaction between midazolam and remifentanil during monitored anesthesia care. Anesthesiology. 1996;85: 1283-1289.
16. Machata A, Gonano C, Holzer A, et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating condition, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg. 2003;97:904-908.
17. Bonnin M, Therre P, Albuisson E, et al. Comparison of propofol target-controlled infusion and inhalational sevoflurane for fiberoptic intubation under spontaneous ventilation. Acta Anaesthesiol Scand. 2007;51:54-59.
18. Lauwers M, Camu F, Breivik H, et al. The safety and effectiveness of remifentanil as an adjuvant sedative for regional anesthesia. Anesth Analg. 1999;88:134-140.
19. Simmons ST, Schleich AR. Airway regional anesthesia for awake fiberoptic intubation. Reg Anesth Pain Med. 2002;27:180-192.
20. Cafiero T, Esposito F, Fraioli G, et al. Remifentanil-TCI and propofol-TCI for conscious sedation during fiberoptic intubation in the acrome-galic patients. Eur J Anaesthesiol. 2008;25:670-674.
21. Grant SA, Breslin DS, Macleod DB, Gleason D, Martin G. Dexmedeto-midine infusion for sedation during fiberoptic intubation: a report of three cases. J Clinic Anesth. 2004;16:124-126.
22. Unger RJ, Gallagher CJ. Dexmedetomidine sedation for awake fiberoptic intubation. Seminars in anesthesia. Perioper Med Pain. 2006; 25:65-70.
23. Schmartz D, Ferring M, Ducart A, Barvais L. Hemodynamics during remifentanil induction by high plasma or effect-site targer controlled infusion. Acta Anaesthesilol Belg. 2007;58:15-18.
24. Rai MR, Parry TM, Dombrovski A, Warner OJ. Remifentanil TCI vs propofol TCI for conscious sedation for awake fiberoptic intubation: A double-blinded randomized controlled trial. Br J Anesthesiol. 2008;100: 125-130.